Working with many rare forms of blood disorders, the Stanford Hematology Program brings together a multispecialty team of experts dedicated to treating leukemia as well as other benign and malignant hematologic disorders.
Overview of Blood Cancers, Leukemia, and Hematological Malignancies
Blood cancers are hematological disorders that affect the cells that make up blood, bone marrow, and lymph. While many hematological cancers are relatively rare, the specialists at the Stanford Hematology Program are experienced in managing even the most complex cases. Our team of world-renowned doctors provides the most advanced diagnostic technologies and treatments available today for both benign and malignant hematologic disorders.
Our goal is to improve the survival and quality of life of patients. Stanford Cancer Center doctors have particular expertise in the management of:
A form of acute myelogenous leukemia (AML) that is caused when part of chromosome 15 and chromosome 17 are swapped in an action called a "translocation." APL accounts for about 5-10% of all cases of AML and is most likely to affect young adults.
A type of blood cancer in which bone marrow and other lymphatic system organs slowly make too many lymphocytes (a type of white blood cell). The term "chronic" means the disease progresses more slowly.
Venous thrombosis is when the blood clot obstructs a vein, and arterial thrombosis is when the blood clot obstructs an artery.
Leukemia is the most common form of cancer in childhood. It affects approximately 3,000 children each year in the United States, accounting for about 30% of childhood cancers. Information about childhood leukemia can be found at the Lucile Packard Children's Hospital, which is within easy walking distance from both the Stanford Cancer Center and Stanford Health Care.
Robert Negrin, MD, Director of Stanford's Blood and Marrow Transplant program on why he left biochemistry to become a hematologist.
Clinical trials are research studies that evaluate a new medical approach, device, drug, or other treatment. As a Stanford Health Care patient, you may have access to the latest, advanced clinical trials.
Open trials refer to studies currently accepting participants. Closed trials are not currently enrolling, but may open in the future.